Abeona Therapeutics (ABEO) Shares Outstanding (2010 - 2026)

Abeona Therapeutics' Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $16.9 million for Q1 2023.

• On a quarterly basis, Shares Outstanding (Entity) rose 187.33% year-over-year to $16.9 million in Q1 2023; TTM through Mar 2023 was $16.9 million, a 187.33% increase from a year earlier, with the FY2022 full-year figure at $7.9 million, up 99.65% from the prior year.
• Shares Outstanding (Entity) grew to $16.9 million in Q1 2023 per ABEO's latest filing, from $7.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $16.9 million in Q1 2023 and bottomed at $1.9 million in Q1 2019.
• The 5-year median for Shares Outstanding (Entity) is $3.9 million (2021), against an average of $4.8 million.
• Across the five-year window, Shares Outstanding (Entity) advanced 1.52% in 2019 and jumped 187.33% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $2.0 million in 2019, then soared by 90.91% to $3.8 million in 2020, then advanced by 2.4% to $3.9 million in 2021, then surged by 99.65% to $7.9 million in 2022, then soared by 115.02% to $16.9 million in 2023.
• Per Business Quant, the three latest ABEO Shares Outstanding (Entity) figures stand at $16.9 million (Q1 2023), $7.9 million (Q4 2022), and $7.7 million (Q3 2022).